STRATIFYER Molecular Pathology GmbH

A multicenter comparison of PD-L1 protein and mRNA expression in urothelial bladder cancer by immunohistochemistry and RT-qPCR (Checkpoint-Typer(C)): A round robin test by the BRIDGE-Consortium Germany (2018) Eckstein M, Wirtz R, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, et al. Conference contribution mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants (2018) Eckstein M, Wirtz RM, Gross-Weege M, Breyer J, Otto W, Stoehr R, Sikic D, et al. Journal article CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making (2018) Worst TS, Weis CA, Stoehr R, Bertz S, Eckstein M, Otto W, Breyer J, et al. Journal article High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma (2018) Breyer J, Wirtz RM, Erben P, Worst TS, Stoehr R, Eckstein M, Bertz S, et al. Journal article A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegib (2018) Baur V, Papadopoulos T, Kazakov D, Agaimy A, Hartmann A, Isbary G, Wirtz RM, Schultz ES Journal article FOXM1 predicts disease progression in non-muscle invasive bladder cancer (2018) Rinaldetti S, Wirtz R, Worst TS, Hartmann A, Breyer J, Dyrskjot L, Erben P Journal article High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients (2018) Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, et al. Journal article Comparison of PD-L1 mRNA expression measured with the CheckPointTyper(R) assay with PD-L1 protein expression assessed with immunohistochemistry (IHC) in lung cancer (NSCLC) (2017) Erber R, Stoehr R, Herlein S, Fuchs F, Veltrup E, Wirtz R, Hartmann A Conference contribution Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance (2017) Erben P, Wezel F, Wirtz R, Martini T, Stein D, Weis CA, Hartmann A, Bolenz C Journal article ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ (2017) Breyer J, Otto W, Wirtz RM, Wullich B, Keck B, Erben P, Kriegmair MC, et al. Journal article